MicroRNA-34a: a potential therapeutic target in human cancer - Test2 - elhamkhani - TriplyDB

MicroRNA-34a: a potential therapeutic target in human cancer

MicroRNA-34a: a potential therapeutic target in human cancer

http://www.wikidata.org/entity/Q27003249

about

Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action Impact of miRNAs on cardiovascular aging Oncogenomic portals for the visualization and analysis of genome-wide cancer data Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer The Receptor Tyrosine Kinase AXL in Cancer Progression Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential Downregulation of B-cell lymphoma/leukemia-2 by overexpressed microRNA 34a enhanced titanium dioxide nanoparticle-induced autophagy in BEAS-2B cells MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells.Verification of microRNA expression in human endometrial adenocarcinoma.MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset.Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms Signaling by exosomal microRNAs in cancer.Dynamic Expression of Novel MiRNA Candidates and MiRNA-34 Family Members in Early- to Mid-Gestational Fetal Keratinocytes Contributes to Scarless Wound Healing by Targeting the TGF-β Pathway.Quantitative assessment of miR34a as an independent prognostic marker in breast cancer.MicroRNAs: New Players in Anesthetic-Induced Developmental Neurotoxicity Investigation of Content, Stoichiometry and Transfer of miRNA from Human Neural Stem Cell Line Derived Exosomes.Regulation of Nuclear Receptor Nur77 by miR-124.Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study.Prognostic significance of MiR-34a in solid tumors: a systemic review and meta-analysis with 4030 patients.The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers.The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to pirarubicin Inhibition of microRNA-34a prevents IL-1β-induced extracellular matrix degradation in nucleus pulposus by increasing GDF5 expression.Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway Progression of mouse skin carcinogenesis is associated with the orchestrated deregulation of mir-200 family members, mir-205 and their common targets.MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression.Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.Stem Cell-Like Properties of CK2β-down Regulated Mammary Cells.MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling.Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma.Emergence of miR-34a in radiation therapy.MiRNA 34a: a therapeutic target for castration-resistant prostate cancer.Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.

P2860

Q26747750-5E08D80E-D9AD-48C2-BB13-929780B8139A Q26773479-3CD3AFA9-15B3-4ADE-BA2C-278D2B21E28F Q26778101-3C728FD4-99BB-464E-BD73-F096D58F3A74 Q26781295-6B3DBC97-FBCF-4529-81B2-3E20E51C925A Q28066481-30D84FAF-942A-40F0-B2A4-5ED30D8DE2BF Q28068756-E5C58525-8C19-4870-B9CA-51594E22ACF1 Q28084310-41640BA7-FE74-4318-8701-F422F6AADF25 Q28394189-962DC798-E87F-4021-98FC-2438756B6AF6 Q33808084-055FF7D4-72EF-4079-9566-28AF39BD7133 Q33816414-AF750E21-7028-4F75-A16D-2865AD99B7C0 Q33849824-D868D65D-BADD-42EB-9A26-0AD3A543B1BD Q33906581-26082F7D-6BF7-4C55-BB2F-D5279E40A25E Q35127713-5749D270-35A0-4D7C-84AF-AE6CE92650CB Q35344075-CBDE2959-68C5-459B-B41E-391C7342BDFA Q35610932-6C9D146E-87D0-469D-BBCD-669929E63E21 Q35677744-C6AB95CB-7718-4695-91E1-C516585DFB85 Q35802248-3300D4B3-2979-4237-83F9-27C1999736FF Q35890359-D2829CBA-D25E-4694-9A9A-BBC2695EB50B Q35913193-2009CA72-195C-41B6-89CF-19A8208BD330 Q35928957-5403DE42-FE44-4936-BE4D-F37C4B9E17A9 Q36114127-7B1CC315-2A25-4059-A391-CF8A919518A2 Q36411504-DBF9398A-0D0B-4A89-AFE4-3FA66FEB04D9 Q36426116-611FF96D-6607-4C87-8107-E03FF74FC00C Q37041036-0E367F38-B8E4-4C14-A1F9-C38A1CE0155A Q37189149-CEC4D852-2542-45A4-A1B6-EE09C1D004F0 Q37347213-5D372938-C885-4B7B-96AA-CC15569F57F8 Q37591581-4B8A88C5-88AF-46EB-8BBA-1C6F91B8FE37 Q37629548-77BC6805-3FB4-469E-80D6-A74EF4DD9263 Q37644875-1560DB15-F215-4EE0-B507-E87F79C08372 Q37706591-47C8D98D-D3DE-464B-854A-3A52E335B04D Q38295568-30D6A05B-A44D-48F8-8900-6ED5C2A27842 Q38331867-FBC4F523-E593-4B87-B39F-C66B83E101E9 Q38572855-75D30479-3AC2-4671-B426-63F32ADA1E9B Q38600155-A586CBFB-8079-4FB3-98D8-8120BEE31C5E Q38637987-A0551282-DA9B-4177-A023-4A678F1118B8 Q38656476-3F991CD5-CE6F-4D6D-860D-6270EE5BDE53 Q38724657-1688AE8A-303E-426E-9C66-4F4A493CDA47 Q38760500-342F21DE-33A0-47EC-B86C-1D52A417EA44 Q38760557-7655C09F-540B-4E2E-AEB0-57DE7646756B Q38789702-5E523A18-4851-43A0-B2A5-C7FE78290E57

P2860

MicroRNA-34a: a potential therapeutic target in human cancer

http://www.wikidata.org/entity/Q27003249

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

MicroRNA-34a: a potential therapeutic target in human cancer

@ast

MicroRNA-34a: a potential therapeutic target in human cancer

@en

MicroRNA-34a: a potential therapeutic target in human cancer

@nl

type

label

MicroRNA-34a: a potential therapeutic target in human cancer

@ast

MicroRNA-34a: a potential therapeutic target in human cancer

@en

MicroRNA-34a: a potential therapeutic target in human cancer

@nl

prefLabel

MicroRNA-34a: a potential therapeutic target in human cancer

@ast

MicroRNA-34a: a potential therapeutic target in human cancer

@en

MicroRNA-34a: a potential therapeutic target in human cancer

@nl

P1433

Q27003249-EA3BCC19-1BCB-44E3-B5CC-F87EDAC6B2F2

P1476

Q27003249-AD6BD00B-9212-4969-9C39-DB7778CA437D

P2093

Q27003249-39AC0462-6B0A-40EE-9B7F-CBEEFE040107

Q27003249-3EEB3B00-5E63-4895-A1CF-492AE8489E2C

Q27003249-AE299A35-9326-4789-AF82-A13287CF2FBF

P275

Q27003249-823B7008-CFF4-461B-BAEC-44B2A405A293

P2860

Q27003249-04B31214-472B-447E-863D-85CF0A1D866F

Q27003249-07985300-F836-4BAA-BFB8-8E51996D9796

Q27003249-085D33E7-EA70-4162-B817-421BA4319741

Q27003249-0AFAC0D4-8BD7-4382-BD91-C2155A37EB5A

Q27003249-0BEB3139-4F82-4821-9D08-95082487BA48

Q27003249-0C4B5F7B-53F1-4A34-9397-785D5BAE3790

Q27003249-0C8F6494-6345-4182-ADFD-8CC7C2328687

Q27003249-1076F1C9-02C5-40AA-9B9A-1426A79F7444

Q27003249-1241DACD-10F7-4ED1-AD51-01FF2F21DED2

Q27003249-155B734F-DC33-4531-998F-D0DF8CA16FC9

P304

Q27003249-11167E32-C1C6-4F61-9604-E51133DE7B9D

P31

Q27003249-A59D5047-BC64-4E81-80F6-CDFD00D52606

Q27003249-C4814C0E-3534-4B15-BF6C-1D93BE1B026E

P3181

Q27003249-F8B9ACC2-F46F-484D-A55E-8BBB7F5184CE

P356

Q27003249-1A8CF7D0-CD80-4004-83F1-9A4386C9886D

P407

Q27003249-D3E60895-503F-4C01-97D3-C6ECF320DF5D

P478

Q27003249-7C1E1C10-AFD9-43D8-A74B-A5C2A93CFFCE

P5008

Q27003249-D41D9E32-2FC1-4F46-99CF-3A4A511636D6

P577

Q27003249-78FB79A5-7A3F-4A1C-B218-463C2B80F8FD

P5875

Q27003249-F0BC5770-B39E-4EBE-BCF0-CD17D3FFAC01

P698

Q27003249-108CDD9F-8293-42E1-86B6-33D59611A1EA

P921

Q27003249-106A5339-EA95-49BB-9093-D9ED61B27775

Q27003249-8AE381CB-C576-49DA-96B1-29F948BF44AE

P932

Q27003249-88A06CCA-345D-4D9B-8AFF-3BFD30BBAF2A

P3181

P356

P1433

Cell Death and Disease

P1476

MicroRNA-34a: a potential therapeutic target in human cancer

@en

P2093

J H Tang

http://www.w3.org/2001/XMLSchema#string

X J Li

http://www.w3.org/2001/XMLSchema#string

Z J Ren

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells

Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium

A microRNA expression signature of human solid tumors defines cancer gene targets

MicroRNAs: target recognition and regulatory functions

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Circulating microRNAs as stable blood-based markers for cancer detection.

miR-34a repression of SIRT1 regulates apoptosis

A microRNA signature of hypoxia

Genome-wide epigenetic regulation of miRNAs in cancer

Cancer statistics, 2008

P304

e1327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1506957

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/CDDIS.2014.270

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264008162

http://www.w3.org/2001/XMLSchema#string

P698

25032850

http://www.w3.org/2001/XMLSchema#string

P921

P932

4123066

http://www.w3.org/2001/XMLSchema#string